Transfer and transition practices in 96 European adult congenital heart disease centres

Corina Thomet1, Markus Schwerzmann2, Werner Budts3

  • 1Center of Congenital Heart Disease, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland; Department of Public Health and Primary Care, KU Leuven, University of Leuven, Leuven, Belgium.

Insights

Formal transition programs for adults with congenital heart disease (CHD) are lacking in Europe, despite structured transfer being common. Most programs need improvement in age- and development-based care for lifelong CHD management.

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Adult Congenital Heart Disease (ACHD)

Background:

  • Congenital heart disease (CHD) requires lifelong management, posing risks for patients even after childhood treatment.
  • Formal transition programs are crucial for seamless, age-appropriate care transfer from pediatric to adult settings.
  • European guidelines emphasize structured transition and transfer protocols for young persons with CHD.

Purpose of the Study:

  • To assess the current state of transfer and transition programs for CHD patients in European Adult Congenital Heart Disease (ACHD) centers.
  • To evaluate the progress in transitional care for CHD over the past decade.

Main Methods:

  • A descriptive, cross-sectional survey was conducted across 96 European ACHD centers.
  • A specialized survey form captured data on transfer and transition practices.
  • A transfer-transition index quantified adherence to quality indicators for successful patient transfer.

Main Results:

  • Only 41.7% of centers offered formal transition programs; 88.5% had structured transfer processes.
  • A 'good' performance on the transfer-transition index was achieved by 31% of centers, with only 4.2% meeting all criteria.
  • Most transition programs utilized dedicated specialists (often nurses), but few offered flexible, early-stage transition planning.

Conclusions:

  • Nearly half of European ACHD centers provide formal transition programs, with most offering structured transfer.
  • Despite improvements, a significant gap remains in implementing age- and development-based approaches in CHD transition care.
  • Further development of comprehensive and individualized transition strategies is needed for optimal lifelong CHD management.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
141
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
120
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
200
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
394
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
589
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
204